CA3090413C — Glucose monitoring and graphical representations in a data management system
Assigned to Abbott Diabetes Care Inc · Expires 2023-10-10 · 3y expired
What this patent protects
A method comprising receiving glucose data from a monitoring device and displaying a graphical user interface having a report selection component, and in response to user selection of one or more reports of the report selection component, generating the selected reports using the…
USPTO Abstract
A method comprising receiving glucose data from a monitoring device and displaying a graphical user interface having a report selection component, and in response to user selection of one or more reports of the report selection component, generating the selected reports using the received glucose data. The selected reports includes: a graphical rendering of glucose levels versus time, where one axis of the graphical rendering corresponds to glucose levels and another axis of the graphical rendering corresponds to time, and the received glucose data for each day of a first plurality of days are overlaid in the graphical rendering; a graphical rendering of which portions of the received glucose data for the first plurality of days were within each of a plurality of predetermined target glucose ranges; and a table displaying statistics corresponding to the received glucose data for each day of a second plurality of days.
Drugs covered by this patent
- Abilify (aripiprazole) · Generic (originally Otsuka/BMS)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.